- Home
- FTK vs SANA Comparison
FTK vs SANA Comparison
Compare FTK & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTK | SANA |
|---|---|---|
| Founded | 1985 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 924.7M | 793.1M |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FTK | SANA |
|---|---|---|
| Price | $25.51 | $3.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $20.00 | $7.80 |
| AVG Volume (30 Days) | 298.7K | ★ 3.0M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 147.06 | 17.24 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $136,092,000.00 | N/A |
| Revenue This Year | $13.33 | N/A |
| Revenue Next Year | $16.38 | N/A |
| P/E Ratio | $216.17 | ★ N/A |
| Revenue Growth | ★ 214.53 | N/A |
| 52 Week Low | $10.96 | $2.61 |
| 52 Week High | $28.50 | $6.55 |
Technical Indicators
Market Signals| Indicator | FTK | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 54.88 | 42.92 |
| Support Level | $15.01 | $3.03 |
| Resistance Level | N/A | $3.41 |
| Average True Range (ATR) | 1.56 | 0.23 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 58.04 | 12.50 |
Price Performance
Historical ComparisonAbout FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.